Latest news
Loading news…
Yamo Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. New York, United States Founded 2015 1-10 employees For Profit
Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 14
- IT spend
- $86K
Company Info
- Founded
- 2015
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 11
- HQ
- New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.1
- Trend (30d)
- 0
- Trend (90d)
- 1.2
Key People at Yamo Pharmaceuticals
CEO
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Yamo Pharmaceuticals
Loading news…
FAQs about Yamo Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.